- Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
-
Date lodged: Monday, 06 March 2017
-
Current Status:
Answered by Shona Robison on 17 March 2017
To ask the Scottish Government whether it will reclassify all medical mesh implant products as high risk, in light of the EU's recent decison to do so.
Answer
It is the responsibility of the MHRA to regulate medical devices in the UK, and the Scottish Government will act as necessary, according to its advice.
- Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
-
Date lodged: Monday, 06 March 2017
-
Current Status:
Answered by Shona Robison on 17 March 2017
To ask the Scottish Government what impact it considers the resignation of two medical mesh-injured members of the Independent Review of Transvaginal Mesh Implants has had on the balance of the group.
Answer
The resignation of the two members was unfortunate, has caused me concern, and I plan to meet with Ms McIlroy and Ms Holmes shortly in order to properly understand their reasons for resigning. I am, however, aware that Ms McIlroy and Ms Holmes have contributed much to the Review over the past three years and would hope that this is reflected in the Review’s final report.
- Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
-
Date lodged: Monday, 06 March 2017
-
Current Status:
Answered by Shona Robison on 17 March 2017
To ask the Scottish Government whether it is content that all available evidence will be included in the final report published by the Independent Review of Transvaginal Mesh Implants.
Answer
I understand that all relevant evidence available has been considered by the Review. The passage of time between the publication of the Interim Report and the forthcoming Final Report is due to the Review awaiting the publication of several key studies.
- Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
-
Date lodged: Monday, 06 March 2017
-
Current Status:
Answered by Shona Robison on 17 March 2017
To ask the Scottish Government whether there is mandatory reporting of adverse incidents that are a result of using medical mesh devices to treat hernias.
Answer
Adverse incidents involving any medical device must be reported as per General Medical Practice guidance.
- Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
-
Date lodged: Monday, 06 March 2017
-
Current Status:
Answered by Shona Robison on 17 March 2017
To ask the Scottish Government how many (a) transobturator mesh tape and (b) prolapse mesh procedures have been carried out by each NHS board in each month since June 2014.
Answer
The number of transobturator mesh tape and prolapse mesh procedures carried out by the NHS between June 2014 to Sep 2016 are set out in the following tables. The numbers of procedures carried out by each Health Board are not broken down by month due to the small numbers of patients involved.
|
NHS Scotland Totals by Month
|
Total
Transobturator Tape
|
Total Transvaginal Mesh
Procedures for
Pelvic Organ Prolapse (POP)
|
Total Transabdominal
Mesh Procedures for
Pelvic Organ Prolapse (POP)
|
|
June 2014
|
26
|
0
|
6
|
July 2014
|
20
|
*
|
*
|
August 2014
|
8
|
0
|
13
|
September 2014
|
9
|
0
|
13
|
October 2014
|
10
|
*
|
14
|
November 2014
|
*
|
*
|
9
|
December 2014
|
*
|
*
|
9
|
January 2015
|
5
|
*
|
7
|
February 2015
|
6
|
*
|
9
|
March 2015
|
9
|
6
|
10
|
April 2015
|
5
|
*
|
9
|
May 2015
|
*
|
*
|
9
|
June 2015
|
8
|
0
|
11
|
July 2015
|
0
|
*
|
*
|
August 2015
|
*
|
0
|
15
|
September 2015
|
*
|
*
|
7
|
October 2015
|
0
|
*
|
17
|
November 2015
|
*
|
0
|
16
|
December 2015
|
*
|
0
|
11
|
January 2016
|
*
|
*
|
12
|
February 2016
|
*
|
*
|
15
|
March 2016
|
*
|
*
|
14
|
April 2016
|
*
|
*
|
20
|
May 2016
|
*
|
*
|
19
|
June 2016
|
*
|
*
|
15
|
July 2016
|
*
|
0
|
11
|
August 2016
|
*
|
*
|
12
|
September 2016
|
*
|
*
|
16
|
Total
|
148
|
38
|
327
|
|
Health Board Totals - June 2014 to September 2016
|
|
Total
Transobturator Tape
|
Total Transvaginal Mesh
Procedures for
Pelvic Organ Prolapse (POP)
|
Total Transabdominal
Mesh Procedures for
Pelvic Organ Prolapse (POP)
|
Golden Jubilee National Hospital
|
0
|
0
|
0
|
NHS Ayrshire and Arran
|
*
|
12
|
*
|
NHS Borders
|
28
|
*
|
*
|
NHS Dumfries and Galloway
|
63
|
*
|
0
|
NHS Fife
|
12
|
5
|
31
|
NHS Forth Valley
|
0
|
*
|
13
|
NHS Grampian
|
5
|
*
|
37
|
NHS Greater Glasgow and Clyde
|
35
|
0
|
116
|
NHS Highland
|
0
|
0
|
*
|
NHS Lanarkshire
|
0
|
6
|
17
|
NHS Lothian
|
*
|
*
|
23
|
NHS Orkney
|
0
|
0
|
0
|
NHS Shetland
|
0
|
0
|
0
|
NHS Tayside
|
*
|
7
|
70
|
NHS Western Isles
|
0
|
0
|
*
|
Non-NHS Provider
|
0
|
*
|
7
|
Note: where a figure is not given, this is to protect patient confidentiality due to the small numbers involved.
Source: NHS National Services Scotland.
- Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
-
Date lodged: Monday, 06 March 2017
-
Current Status:
Answered by Shona Robison on 17 March 2017
To ask the Scottish Government what administrative, emotional and legal support it provides to lay members of the Independent Review of Transvaginal Mesh Implants group who have resigned.
Answer
The Independent Review’s secretariat has provided support to all members of the Review. This has included, amongst other things, the arranging meetings at convenient times and in appropriate accommodation, the arranging of teleconferencing facilities, the provision of hard copy papers, the refunding of travelling expenses, and other assistance upon request. Scottish Government officials are unable to provide legal advice.
- Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
-
Date lodged: Monday, 06 March 2017
-
Current Status:
Answered by Shona Robison on 17 March 2017
To ask the Scottish Government what assessment it has made of the average cost of (a) mesh and (b) non-mesh treatments for stress urinary incontinence and pelvic organ prolapse.
Answer
The Scottish Government has not made an assessment of these costs.
- Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
-
Date lodged: Monday, 06 March 2017
-
Current Status:
Answered by Shona Robison on 17 March 2017
To ask the Scottish Government under what circumstances it considers that the use of medical mesh would be unavoidable, and whether the report of the Independent Review of Transvaginal Mesh Implants will confirm and describe these situations.
Answer
Decisions around the circumstances in which the use of mesh in any individual patient’s treatment is appropriate are a matter between the patient and the clinicians involved in her case. The Independent Review is expected to publish its final report during the spring. Health Boards will take appropriate action depending on the report's recommendations.
- Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
-
Date lodged: Monday, 06 March 2017
-
Current Status:
Answered by Maureen Watt on 16 March 2017
To ask the Scottish Government, further to the answer to question S5W-06893 by Maureeen Wattr on 24 February 2017, noting that this funding was listed in both the draft 2016-17 budget and the draft 2017-18 budget, whether the delivery of £150 million funding began in the financial year 2016-17 or will begin in 2017-18, and what the final financial year of the allocation of funds will be.
Answer
The commitment within the Scottish budget to invest £150 million over the next five years is from 2017-18 to 2021-22. £30 million is earmarked for allocation in 2017-18. The allocation profile for future years is currently being agreed, and will be subject to future Spending Review decisions.
- Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
-
Date lodged: Monday, 06 March 2017
-
Current Status:
Answered by Maureen Watt on 16 March 2017
To ask the Scottish Government, further to the answer to question S5W-06893 by Maureen Watt on 24 February 2017, what percentage rate of increase above the overall growth in the frontline NHS budget will be allocated to mental health.
Answer
The commitment in the Scottish budget is that in future years investment in mental health will grow at a rate above the overall growth in the frontline budget. No specific percentage rate has been agreed. NHS Boards will report on mental health expenditure through the normal route in due course.